IFNA1 and COVID-19: It was demonstrated that, in the BALF of COVID-19 patients, the increased expression of IFN-α and IFN-β correlates with the morbidity (Broggi et al. 2020), suggesting the potential pathogenesis of IFN-Is during SARS-CoV-2 infection.